4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-25-031991
President/CEO bought 5,500 shares at an average $1.84 ($10,110)
From the SEC's structured data for this filing
Trades in this filing
Gilad Oren · President/CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-03 | Purchase : show line 1 in the form | +3,003 | $1.87 | $5,616 | 343,123 | D |
| 2025-04-03 | Purchase : show line 2 in the form | +2,497 | $1.80 | $4,495 | 345,620 | D |
| Open-market purchases · 5,500 sh · avg $1.84 · $10,110 | ||||||
Loading xslF345X05/tm2511518-1_4seq1.xml…